129 related articles for article (PubMed ID: 12459929)
1. Lobeline does not serve as a reinforcer in rats.
Harrod SB; Dwoskin LP; Green TA; Gehrke BJ; Bardo MT
Psychopharmacology (Berl); 2003 Feb; 165(4):397-404. PubMed ID: 12459929
[TBL] [Abstract][Full Text] [Related]
2. Lobeline attenuates d-methamphetamine self-administration in rats.
Harrod SB; Dwoskin LP; Crooks PA; Klebaur JE; Bardo MT
J Pharmacol Exp Ther; 2001 Jul; 298(1):172-9. PubMed ID: 11408539
[TBL] [Abstract][Full Text] [Related]
3. The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats.
Benwell ME; Balfour DJ
Br J Pharmacol; 1998 Nov; 125(6):1115-9. PubMed ID: 9863636
[TBL] [Abstract][Full Text] [Related]
4. The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.
Beckmann JS; Siripurapu KB; Nickell JR; Horton DB; Denehy ED; Vartak A; Crooks PA; Dwoskin LP; Bardo MT
J Pharmacol Exp Ther; 2010 Dec; 335(3):841-51. PubMed ID: 20805303
[TBL] [Abstract][Full Text] [Related]
5. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
Meyer AC; Neugebauer NM; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
J Neurochem; 2013 Oct; 127(2):187-98. PubMed ID: 23875705
[TBL] [Abstract][Full Text] [Related]
6. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
[TBL] [Abstract][Full Text] [Related]
7. A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats.
Xi ZX; Kleitz HK; Deng X; Ladenheim B; Peng XQ; Li X; Gardner EL; Stein EA; Cadet JL
Neuroscience; 2009 Jun; 161(2):392-402. PubMed ID: 19336247
[TBL] [Abstract][Full Text] [Related]
8. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
9. Lobelane decreases methamphetamine self-administration in rats.
Neugebauer NM; Harrod SB; Stairs DJ; Crooks PA; Dwoskin LP; Bardo MT
Eur J Pharmacol; 2007 Sep; 571(1):33-8. PubMed ID: 17612524
[TBL] [Abstract][Full Text] [Related]
10. Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
Miller DK; Crooks PA; Teng L; Witkin JM; Munzar P; Goldberg SR; Acri JB; Dwoskin LP
J Pharmacol Exp Ther; 2001 Mar; 296(3):1023-34. PubMed ID: 11181937
[TBL] [Abstract][Full Text] [Related]
11. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
12. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
13. The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.
Beckmann JS; Denehy ED; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2012 Mar; 220(2):395-403. PubMed ID: 21938414
[TBL] [Abstract][Full Text] [Related]
14. Lobeline produces conditioned taste avoidance in rats.
Harrod SB; Dwoskin LP; Bardo MT
Pharmacol Biochem Behav; 2004 May; 78(1):1-5. PubMed ID: 15159128
[TBL] [Abstract][Full Text] [Related]
15. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.
Wee S; Wang Z; Woolverton WL; Pulvirenti L; Koob GF
Neuropsychopharmacology; 2007 Oct; 32(10):2238-47. PubMed ID: 17327886
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent attenuation of heroin self-administration with lobeline.
Hart N; Rocha A; Miller DK; Nation JR
J Psychopharmacol; 2010 Jan; 24(1):51-5. PubMed ID: 20130110
[TBL] [Abstract][Full Text] [Related]
17. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic ligands modulate ethanol-induced dopamine function in mice.
Sajja RK; Dwivedi C; Rahman S
Pharmacology; 2010; 86(3):168-73. PubMed ID: 20714207
[TBL] [Abstract][Full Text] [Related]
19. Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
Horton DB; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2011 Oct; 339(1):286-97. PubMed ID: 21778282
[TBL] [Abstract][Full Text] [Related]
20. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking.
Anderson SM; Schmidt HD; Pierce RC
Neuropsychopharmacology; 2006 Jul; 31(7):1452-61. PubMed ID: 16205775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
